A newly developed laboratory tool can, within hours, help to identify specific viruses which can be used to destroy variants ...
Researchers have discovered a promising new vaccine strategy for treating a specific type of breast cancer. The innovative approach targets human epidermal growth factor receptor 2-positive, estrogen ...
For patients with type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with a reduced ...
Targeted CRISPR lipid nanoparticles eliminated 50% of tumors in mice with head and neck cancer.
Cellogen Therapeutics’ CAR T cell technology introduces a bi-specific approach to cancer immunotherapy. Unlike conventional ...
Our Bureau, Bengaluru Wednesday, March 19, 2025, 13:15 Hrs [IST] ...
PR+ breast cancer responds well to hormone therapy, underscoring the need for molecular insight and targeted treatment ...
An in-depth analysis of ER+ breast cancer, focusing on its prevalence, molecular biology, current treatments, and emerging ...
Each cell in your body relies on precise communication with other cells to function properly. At the center of this process ...
Moffitt Cancer Center researchers have discovered a promising new vaccine strategy for treating a specific type of breast ...
GLP-1 RA use linked to lower risks for myelodysplastic syndromes, myeloproliferative neoplasms compared with metformin. (HealthDay News) — For patients with type 2 diabetes (T2D), glucagon-like ...